154 related articles for article (PubMed ID: 36647795)
1. Onychomatricoma: a clinicopathological, immunohistochemical, and molecular study of 10 cases highlighting recurrent RB1 deletion and the potential diagnostic value of LEF-1.
Perrin C; Pedeutour F; Coutts M; Ambrosetti D; Dadone-Montaudié B
Histopathology; 2023 Apr; 82(5):767-778. PubMed ID: 36647795
[TBL] [Abstract][Full Text] [Related]
2. Superficial acral fibromyxoma: clinicopathological, immunohistochemical, and molecular study of 11 cases highlighting frequent Rb1 loss/deletions.
Agaimy A; Michal M; Giedl J; Hadravsky L; Michal M
Hum Pathol; 2017 Feb; 60():192-198. PubMed ID: 27825811
[TBL] [Abstract][Full Text] [Related]
3. RB1 loss in the mesenchymal component of onychomatricoma.
Liu Y; Zou D; Huang Q; Wang L
J Cutan Pathol; 2023 Dec; 50(12):1094-1098. PubMed ID: 37596842
[TBL] [Abstract][Full Text] [Related]
4. Onychomatricoma: new clinical and histological features. A review of 19 tumors.
Perrin C; Baran R; Balaguer T; Chignon-Sicard B; Cannata GE; Petrella T; Michiels JF
Am J Dermatopathol; 2010 Feb; 32(1):1-8. PubMed ID: 20098079
[TBL] [Abstract][Full Text] [Related]
5. Acral fibromyxoma with loss of Rb1 by immunohistochemistry and fluorescence in situ hybridization: A diagnostically exploitable marker.
Motanagh S; Bridge JA; Linos K
J Cutan Pathol; 2021 Feb; 48(2):295-301. PubMed ID: 32524651
[TBL] [Abstract][Full Text] [Related]
6. Onychomatricoma Micropapilliferum, a New Variant of Onychomatricoma: Clinical, Dermoscopical, and Histological Correlations (Report of 4 Cases).
Perrin C
Am J Dermatopathol; 2020 Feb; 42(2):103-110. PubMed ID: 31436573
[TBL] [Abstract][Full Text] [Related]
7. Onychomatricoma is not a subtype of superficial acral fibromyxoma: Can immunohistochemistry help in the differential diagnosis?
Perrin C; Coutts M
J Cutan Pathol; 2024 Jun; 51(6):439-440. PubMed ID: 38527773
[No Abstract] [Full Text] [Related]
8. Proliferating Onychomatricoma. Clinical, Dermoscopical, and Pathologic Features of Onychomatricoma New Variant Resembling Onycholemmal/Squamous Cell Carcinoma.
Perrin C; Ambrosetti D; Balme B; Thomas L
Am J Dermatopathol; 2020 Nov; 42(11):827-834. PubMed ID: 32271204
[TBL] [Abstract][Full Text] [Related]
9. The onychomatricoma: additional histologic criteria and immunohistochemical study.
Perrin C; Baran R; Pisani A; Ortonne JP; Michiels JF
Am J Dermatopathol; 2002 Jun; 24(3):199-203. PubMed ID: 12140434
[TBL] [Abstract][Full Text] [Related]
10. Superficial acral fibromyxoma and other slow-growing tumors in acral areas.
Schwager ZA; Mannava KA; Mannava S; Telang GH; Robinson-Bostom L; Jellinek NJ
Cutis; 2015 Feb; 95(2):E15-9. PubMed ID: 25750972
[TBL] [Abstract][Full Text] [Related]
11. Loss of retinoblastoma in pleomorphic fibroma: An immunohistochemical and genomic analysis.
Hinds B; Agulló Pérez AD; LeBoit PE; McCalmont TH; North JP
J Cutan Pathol; 2017 Aug; 44(8):665-671. PubMed ID: 28543636
[TBL] [Abstract][Full Text] [Related]
12. Fibroepithelial Stromal Polyp of the Vulvovaginal Region as Part of the RB1 Family of Tumors: Friend or Foe?
Cordier F; Van Roy N; Matthys B; De Paepe P; Van de Vijver K; Van Dorpe J; Creytens D
Int J Gynecol Pathol; 2024 May; 43(3):215-220. PubMed ID: 37922949
[TBL] [Abstract][Full Text] [Related]
13. Superficial CD34-positive fibroblastic tumour: a clinicopathological and immunohistochemical study of an additional series.
Lao IW; Yu L; Wang J
Histopathology; 2017 Feb; 70(3):394-401. PubMed ID: 27636918
[TBL] [Abstract][Full Text] [Related]
14. Myxoid onychomatricoma: an unusual variant of a rare nail unit tumor.
Stewart CL; Sobanko JF; Rubin AI
Am J Dermatopathol; 2015 Jun; 37(6):473-6. PubMed ID: 25830718
[TBL] [Abstract][Full Text] [Related]
15. Superficial acral fibromyxoma: immunohistochemical and ultrastructural analysis of a case, with literature review.
Pasquinelli G; Foroni L; Papadopoulos F; Dicandia L; Bisceglia M
Ultrastruct Pathol; 2009 Dec; 33(6):293-301. PubMed ID: 19929177
[TBL] [Abstract][Full Text] [Related]
16. Superficial acral fibromyxoma: report of 4 cases with CD10 expression and lipomatous component, two previously underrecognized features.
Tardío JC; Butrón M; Martín-Fragueiro LM
Am J Dermatopathol; 2008 Oct; 30(5):431-5. PubMed ID: 18806483
[TBL] [Abstract][Full Text] [Related]
17. [Superficial acral fibromyxoma in a sub-matricial location: An unusual variant].
Chabbab F; Metz T; Saez Beltran L; Theunis A; Richert B
Ann Dermatol Venereol; 2014 Feb; 141(2):94-105. PubMed ID: 24507203
[TBL] [Abstract][Full Text] [Related]
18. [Superficial acral fibromyxoma: a CD34+ periungual tumor].
Messeguer F; Nagore E; Agustí-Mejias A; Traves V
Actas Dermosifiliogr; 2012; 103(1):67-9. PubMed ID: 22078141
[No Abstract] [Full Text] [Related]
19. [Superficial acral fibromyxoma of finger: report of a case with review of literature].
Wang QF; Pu Y; Wu YY; Wang J
Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):682-5. PubMed ID: 20078973
[TBL] [Abstract][Full Text] [Related]
20. Digital fibromyxoma (superficial acral fibromyxoma): a detailed characterization of 124 cases.
Hollmann TJ; Bovée JV; Fletcher CD
Am J Surg Pathol; 2012 Jun; 36(6):789-98. PubMed ID: 22367301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
